Sangeetha Paramasivan

University of Bristol

Papers

1

Total Citations

88

H-Index

1

About

Sangeetha Paramasivan is a leading health services researcher whose work centers on patient-reported outcomes, surgical recovery, and the real-world evaluation of minimally invasive procedures. Her major contributions lie in rigorously comparing surgical techniques through randomized controlled trials that prioritize the patient’s own experience. She is best known for her pivotal role in the VIOLET trial, which demonstrated that video-assisted thoracoscopic surgery (VATS) for lung cancer leads to superior physical function recovery compared to open lobectomy, as measured by self-reported outcomes. This landmark study, published in 2022 and already garnering 88 citations, has reshaped clinical understanding of recovery after thoracic surgery. Beyond this, Paramasivan’s research consistently bridges the gap between clinical efficacy and patient-centered care, ensuring that surgical innovations are evaluated not just for safety, but for their impact on quality of life. Her work is highly influential among surgeons, trialists, and health policy researchers, and she is recognized for advancing evidence-based practice in thoracic oncology. For students and researchers, her career exemplifies how thoughtful trial design and patient-reported metrics can drive meaningful change in surgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
88
Total Citations
88
Avg Citations/Paper
🏆 Most Cited Paper
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT
88 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University of Bristol

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago